HIV This Week issue #37
Welcome to the thirty-seventh issue of HIV This Week! In this issue, we cover immunology (infected at birth but healthy in adolescence – immune systems fight back but how?; could long term antiretroviral treatment succeed in depleting HIV’s reservoirs?; avoiding the intercurrent infections which could top up HIV’s reservoirs), treatment – immune reconstitution inflammatory syndrome: fighting back too fast creates an inflammatory storm; which tuberculosis patients are more likely to get IRIS - immune reconstitution inflammatory syndrome?), migration and mobility (mobility moves foreign policy; encouragingly low HIV prevalence among conflict-affected and displaced people in 7 sub-Saharan African countries - but still much to be done); men who have sex with men and methamphetamine use (providers need to ask to know), sexually transmitted infections (bacterial vaginosis: what would it mean if Herpes simplex virus type-2 (HSV-2) facilitates its development?), prevention of mother-to-child-transmission (no doubt about evidence of efficacy - implementation is the real issue now), surveillance (tailoring second-generation HIV surveillance in Romania to ‘know your epidemic’), and basic science (stopping the third major HIV enzyme - integrase; molecular umbrellas: a promising new door opens in microbicide development to prevent both HIV and HSV).
To find out how you can access a majority of scientific journals free of charge, please click on the Journal Access tab above.
We want to be as helpful to you as we can, so please let us know what your interests are and what you think of HIV This Week by posting a comment on the blog (click on the Add Your Comments tab above) or by sending one to hivthisweek@unaids.org. If you would like to recommend an article for inclusion in HIV This Week, please let us know.
Don’t forget that you can find a wealth of information on the HIV epidemic and responses to it at http://www.unaids.org.
For full pdf access of this issue: HIV This Week issue #37
Cate Hankins | Tania Lemay |
| Chief Scientific Adviser | Interim Research Officer |
Post new comment